Ottobock SE & Co. KGaA (ETR:OBCK)

Market Cap	3.65B
Revenue (ttm)	1.66B +10.9%
Net Income	59.20M +20.9%
EPS	10.52 +17.6%
Shares Out	63.99M
PE Ratio	5.42
Forward PE	20.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,119
Average Volume	54,240
Open	56.60
Previous Close	55.90
Day's Range	56.30 - 57.65
52-Week Range	53.40 - 76.35
Beta	n/a
RSI	41.78
Earnings Date	Mar 19, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA designs and develops medical technology products and solutions for the people with limited mobility in the fields of prosthetics, orthotics, human mobility, and medical care worldwide. The company develops exo-prosthetics products, including microprocessor-controlled lower limb prosthesis systems, bionic prosthetic systems, michelangelo prosthetic hands, and liner and closure systems; temporary fittings for after accidents and injuries; ankle sprains products; fittings for partial paralysis of legs; and mechatronic orthos...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 9,256
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: OBCK

Financial Performance

In 2024, Ottobock SE & Co. KGaA's revenue was 1.60 billion, an increase of 7.33% compared to the previous year's 1.50 billion. Earnings were 30.20 million, a decrease of -38.32%.